Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid

European Journal of Clinical Pharmacology

Volumn 59, Issue 12, 2004, Pages 879-882

  Ucar, M ^a   Neuvonen, M ^b   Luurila, H ^b   Dahlqvist, R ^c   Neuvonen, P J ^b   Mjorndal T ^c  

^a Varnamo Hospital   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carbamazepine; Serum concentrations; Simvastatin

Indexed keywords

CARBAMAZEPINE; DRUG METABOLITE; HERMOLEPSINE; SIMVASTATIN; SIMVASTATIN ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; AREA UNDER CURVE; CARBAMAZEPINE; CROSS-OVER STUDIES; DRUG INTERACTIONS; HALF-LIFE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; SIMVASTATIN;

EID: 1542407269     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0700-5     Document Type: Article

References (34)

1. 450s. Drug Metab Dispos 25:1191-1199
2. Landrum Michalets E (1998) Review of therapeutics. Pharmacotherapy 18:84-112
3. Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J et al (2000) Carbamazepine-nefazodone interaction in healthy subjects. J Clin Psychopharmacol 20:45-53
4. 450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 66:589-593
5. Eap CB, Yasui N, Kaneko S, Baumann P, Powell K, Otani K (1999) Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and its metabolites. Ther Drug Monit 21:166-170
6. Lucas RA, Gilfillan DJ, Bergstom RF (1988) A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism. Eur J Pharmacol 54:639-643
7. Jerling M, Lindström L, Bondesson U, Bertilsson L (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 16:368-374
8. 450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochem Pharmacol 44:2307-2314
9. Kantola T, Kivistö KT, Neuvonen PJ (1998) Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther 64:177-182
10. Neuvonen PJ, Kantola T, Kivistö KT (1998) Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther 63:3332-3341
11. Arnadottir M, Eriksson LO, Thysell H, Karkas JD (1993) Plasma concentration profiles of simvastatin 3-hydroxy-3-metyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without cyclosporin. Nephron 65:410-413
12. Kantola T, Kivistö KT, Neuvonen PJ (1998) Effect of itraconazole on the pharmacokinetics of atorvastatin. Clin Pharmacol Ther 64:58-65
13. Segaert MF, De-Soete C, Vandewiele I, Verbanck J (1996) Drug-interaction-induced rhabdomyolysis. Nephrol Dial Transplant 11:1846-1847
14. Wu CY, Benet LZ, Hebert MF, Gupta SK, Rowland M, Gomez DY et al (1995) Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 58:492-497
15. Backman JT, Kyrklund C, Kivistö KT, Wang JS, Neuvonen PJ (2000) Plasma concentrations of active simvastatin acid are increased by gemfibrozil. Clin Pharmacol Ther 68:122-129
16. 450. Biochem Pharmacol 51:591-598
17. Kogan AD, Orensterin S (1990) Lovastatin-induced acute rhabdomyolysis. Postgrad Med J 66:293-296
18. Duell PB, Connor WE, Illingworth DR (1998) Rhabdomyolysis after taking atorvastatin with gemfibrozil. Am J Cardiol 81:368-369
19. Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli WE (1998) Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet 351:1929-1930
20. Jacobson RH, Wang P, Glueck CJ (1997) Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone (letter) JAMA 277:296-297
21. Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ (2000) Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther 68:592-597
22. Bertilsson L, Tybring G, Widen J, Chang M, Tomson T (1997) Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. Br J Pharmacol 44:186-189
23. 450 subfamilies in rats. Chemico-Biological Interactions 117:257-268
24. Baciewicz AM (1986) Carbamazepine drug interaction. Ther Drug Monit 8:305-317
25. Iwahashi K, Miyatake R, Suwaki H, Hosokawa K, Ichikawa Y (1995) The drug-drug interaction effects of haloperidol on plasma carbamazepine levels. Clin Neuropharmacol 18:233-236
26. Jerling M, Lindström L, Bondesson U, Bertilsson L (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 16:368-374
27. Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS et al (1995) Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol 15:327-333
28. Bertilsson L, Höjer B, Tybring G, Osterloh J, Rane A (1980) Autoinduction of carbamazepine metabolism in children studied with a stabile isotope technique. Clin Pharmacol Ther 27:83-88
29. McNamara PJ, Colburn WA, Gibaldi M (1979) Time course of carbamazepine self-induction. J Pharmocokinet Biopharm 7:63-68
30. Pitlick WH, Levy RH (1977) Time-dependent kinetics I: exponential autoinduction of carbamazepine in monkeys. J Pharm Sci 66:647-649
31. Pitlick WH, Levy RH, Troupin AS, Green JR (1976) Pharmacokinetic model to describe self-induced decreases in steady-state concentrations of carbamazepine. J Pharm Sci 65:462-463
32. Mikati MA, Browne TR, Collin JF (1989) Time course of carbamazepine autoinduction. The VA Cooperative Study No. 118 Group. Neurology 39:592-594
33. Scheyer RD, Cramer JA, Mattson RH (1994) A pharmacodynamic approach to the estimate of carbamazepine autoinduction. J Pharm Sci 84:491-494
34. Murphy MJ, Dominiczak MH (1999) Efficacy of statin therapy: possible effect of phenytoin. Postgrad Med J 75:359-360